Clinical Research Directory
Browse clinical research sites, groups, and studies.
3 clinical studies listed.
Filters:
Tundra lists 3 Progesterone clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07248046
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.
Gender: FEMALE
Ages: 16 Years - 45 Years
Updated: 2026-01-13
1 state
NCT07173361
Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)
The goal of this clinical trial is to learn if micronized progesterone (PROMETRIUM®) influences the muscle-building response to resistance exercise in healthy premenopausal women aged 18-30 years. The main questions it aims to answer are: 1. Does progesterone change the rate of muscle protein synthesis after exercise? 2. Does progesterone alter the difference in synthesis between an exercised leg and a rested leg? Researchers will compare micronized progesterone to a placebo to see if progesterone changes the way skeletal muscle adapts to resistance exercise. Participants will: * Take two oral doses of progesterone (400 mg total, 34 and 10 hours before testing) or placebo * Complete a unilateral leg extension exercise session in the lab * Receive an infusion of a stable isotope tracer and provide blood samples * Undergo muscle biopsies from the exercised and rested legs
Gender: FEMALE
Ages: 18 Years - 30 Years
Updated: 2025-09-25
1 state
NCT06928844
Role of Low Dose Injectable Progesterone in Triggering Ovulation
The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.
Gender: FEMALE
Ages: 20 Years - 35 Years
Updated: 2025-04-16